Geneos Wealth Management’s BlackRock ESG Capital Allocation Term Trust ECAT Stock Holding History
Bought
Maintained
Sold
Other funds holding ECAT
SCM
PCM
AAM
Geneos Wealth Management's ECAT Position: Q3 2025 in Review
Geneos Wealth Management sold out of BlackRock ESG Capital Allocation Term Trust (ECAT) in Q3 2025, closing a stake of 3,155 shares — an estimated $50.7K sold.
Geneos Wealth Management first reported a position in ECAT in Q1 2025 and held it in 2 quarters. The position peaked at $101K in Q1 2025. 74 funds tracked by Wall St. Rank hold ECAT as of Q3 2025.
- Geneos Wealth Management reported no remaining BlackRock ESG Capital Allocation Term Trust position as of Q3 2025 after selling out during the quarter.
- Geneos Wealth Management sold 3,155 BlackRock ESG Capital Allocation Term Trust shares in Q3 2025, an estimated $50.7K.
- Geneos Wealth Management first reported a position in BlackRock ESG Capital Allocation Term Trust in Q1 2025 and held it in 2 quarters.
- Geneos Wealth Management's BlackRock ESG Capital Allocation Term Trust position peaked at $101K in Q1 2025.
- 74 funds tracked by Wall St. Rank held BlackRock ESG Capital Allocation Term Trust as of Q3 2025.
Based on Geneos Wealth Management's 13F filing for Q3 2025, filed 22 Oct 2025.